Amy Pappert is a Dermatology physician affiliated with Rutgers. OpenAlex indexes 38 publications with 578 citations (h-index 13); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Worlds Fair Dr
Suite 2400
Somerset, NJ 088731344
Telephone
732-235-7765Provider last certified this registry record 23 Jul 2021.
Clinical trials
- Oregano Ointment vs. Standard Treatment for Pediatric Atopic Dermatitis
Sponsor: Rutgers, The State University of New Jersey
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
24 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Galderma Laboratories, L.P.Program year20251 payment
- Janssen Biotech, Inc.Program year20251 payment
- ABBVIE INC.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
27.5%Corticosteroid18.5%Triamcinolone Acetonide61%Triamcinolone acetonide22%Halobetasol Propionate9%Desoximetasone7%Part D + Part B<11 patientsInterleukin-4 Receptor alpha Antagonist5.9%Dupixent Pen100%Part D<11 patients+ 2 more classes in this area
Anti-infectives
23.8%Azole Antifungal11.9%Ketoconazole100%Part D≥57 patientsNitroimidazole Antimicrobial5%Metronidazole100%Part D≥27 patients+ 4 more classes in this area
Cancer & immunology
19%TNF inhibitor7%Enbrel Sureclick41%Humira(Cf) Pen41%Humira Pen18%Part D<11 patientsInterleukin-17A Antagonist5.5%Cosentyx Sensoready (2 Pens)66%Taltz Autoinjector34%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Severe Cutaneous Adverse Reactions in Hospitalized Children: A Pilot Validation Study
Pharmacoepidemiology and Drug Safety
2024 - Use of Optical Coherence Tomography images to Differentiate Between Normal Skin, Skin Lesions, and Melanoma: A Pilot Study
Journal of Clinical and Medical Images
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Sherine Gabriel, MD
Rutgers
Julius Gardin, MD
Rutgers
Abraham Aviv, MD
Rutgers
Partho Sengupta, MD, DM
Rutgers
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”